IL15 and neoplasm: We speculate that a longer observation period would have been necessary, as only around day 19 critical amounts of IL-15-responsive effector cells necessary for anti-tumor responses were reached, but this was not possible due to ethical reasons and limitation by onset of Graft-versus-host-disease.